Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Nova Paid Stream

 

Sub-Saharan Africa invests and insources during pandemic

The direct health impact of COVID-19 on sub-Saharan Africa has so far been significantly less than expected. But economic activity has fallen sharply and a vaccine impact is not expected until late next year. Panellists from Anadach, the IFC, Columbia Africa, AfyA Care and Nyaho Medical Centre talk about consolidation, supply chains and teledensity.

Bringing costs down in South East Asia

HBI State of the Regions continued on Tuesday morning with a look at SE Asia. It's "overloaded" in some parts with "substantial coverage gaps" in others, with big provider/payor conflict in most. Eduardo Banzon from the Asian Development Bank, Cole Sirucek from DocDoc, and Angus Slater from Bupa talk about the biggest challenges and opportunities on the continent.

At $2.4bn, Rede D’Or IPO would be emerging market hospital record

Brazil's largest private hospital chain Rede D'Or's December 10 IPO could raise US$2.4bn, which would make it the largest emerging market hospital listing ever and second overall. That is despite the fact 2020 revenue is flat and net profit is down 80% due to COVID-19.

Indian inbound medical travel ‘a trickle’ as operators consider costs

Medical travel to India is still 'a trickle' compared to pre-COVID figures although restrictions have also increased the supply of specialists locally, said panellists at HBI's State of the Region's South Asia session. Like elsewhere, the pandemic has forced a re-think of how operators manage costs. 

Payor reforms loom in GCC as COVID/expat exodus bites

Payors are maturing and providers are suffering from the double whammy of COVID and a declining expat population, said panellists at HBI's State of the Regions webinar on Middle East & North Africa (MENA). Other topics including hedging risk, public sector reform and how global trends are manifesting in the region.

Emerging market lab roundup

HBI rounds up the latest news from the world's largest emerging market laboratories, including Grupo Fleury in Brazil striking a deal with a rival, and lab activity normalising in India.

NMC beats 9-month forecast, lenders submit claims, and EY faces “£1bn+” lawsuit

In-administration global operator NMC Health's revenues are nearly 10% ahead of its business plan for 2020, while the deadline for creditors to submit claims has passed. Meanwhile, administrators Alvarez & Marsal (A&M) are reportedly preparing to sue accounting firm EY over its auditing of NMC for a reported £1bn or more.

Find Us